Core Compendium & Supplier Audit
-
Compendium Home
Overview of the Delta Peptides editorial reference, receptor signaling mechanisms, pharmacokinetic principles, regulatory status table, and featured supplier audit summary.
-
Supplier Compendial Compliance Audit
Six-criterion evaluation comparing USP Reference Standards, EDQM Ph. Eur. CRS, Sigma-Aldrich PSS, MedChemExpress, Oath Research, and a regional research catalogue composite.
-
What Are Peptides?
Foundational biochemistry of amide bond formation, solid-phase peptide synthesis (SPPS), structural conformations, functional classes, and receptor signaling.
-
Clinical Research & Evidence Landscape
Overview of clinical trial phases, oncology, metabolic, cardiovascular, and neurological peptide investigations, delivery systems, and pharmacovigilance.
Individual Compound Monographs (11 Entries)
| Monograph Entry | CAS Registry No. | Molecular Mass | Primary Pharmacological Class | Oath Research Catalog Association |
|---|---|---|---|---|
| AOD-9604 | 221231-10-3 | 1817.07 g/mol | Cyclic hGH(176–191) lipolytic fragment | Carried as AOD9604 (View product) |
| BPC-157 | — | 15-residue pentadecapeptide | Gastric pentadecapeptide (VEGFR2 / eNOS axis) | Carried as BPC-157 (View product) |
| Cerebrolysin | Biological mixture | Low-MW peptide fraction | Porcine brain-derived peptidergic preparation | No verified public Oath listing in the supplied catalog |
| CJC-1295 | — | 29-residue GHRH(1–29) core | Tetrasubstituted GHRH(1–29) analog | Carried as CJC-1295 (View product) and CJC-1295/Ipamorelin (View blend) |
| Epithalon | — | 4-residue tetrapeptide | Synthetic tetrapeptide (Ala-Glu-Asp-Gly) | Carried as Epithalon (View product) |
| GHK-Cu | — | Tripeptide-Cu(II) complex | Gly-His-Lys copper(II) coordination complex | Carried as GHK-Cu (View product) |
| GHRP-6 | 87616-84-0 | 873.01 g/mol | First-generation hexapeptide GHSR-1a agonist | No verified public Oath listing in the supplied catalog |
| Hexarelin | 140703-51-1 | 887.04 g/mol | Methylated hexapeptide GHSR-1a / CD36 agonist | No verified public Oath listing in the supplied catalog |
| Ipamorelin | — | 711.86 g/mol | Selective pentapeptide GHSR-1a agonist | Carried as Ipamorelin (View product) |
| Sermorelin | — | 29-residue polypeptide | N-terminal GHRH(1–29)-NH2 fragment | No verified public Oath listing in the supplied catalog |
| TB-500 | See monograph (distinct from full-length Tβ4) | Synthetic fragment (not 43-residue Tβ4) | Actin-regulating fragment (monograph also reviews full-length Thymosin β4 research separately; TB-500 is not full-length thymosin beta-4) | Carried as TB-500 (View product) |
Physiological System Reviews (4 Entries)
- Cardiovascular Applications — Endothelial repair, angiogenesis, GHSR-1a/CD36 myocardial signaling, and cardiovascular study endpoints.
- Neurological Applications — Blood-brain barrier delivery considerations, neurotrophic peptide preparations, and neuroprotection studies.
- Regenerative Medicine — Musculoskeletal and dermal tissue remodeling, extracellular matrix synthesis, and material qualification standards.
- Wound Healing — Angiogenesis, fibroblast migration, collagen remodeling, and wound-healing study endpoints.
Analytical Handling, Pharmacology & Safety Explainers (5 Entries)
- Trial Dosing & Prescriber Framework — Why human dosing is exclusively a licensed prescriber's decision, physiological determinants of response variability, and pharmacokinetic considerations.
- Multi-Peptide Co-Administration & Receptor Cross-Talk — Mechanistic basis of complementary receptor pathways in research and the evidence limitations of multi-peptide combinations.
- Safety, Quality Risks & FDA Regulatory Framework — Contamination hazards, hypersensitivity recognition, interaction risks, and FDA bulk drug substances list status as of April 22, 2026.
- Adverse Event Profiles in Published Trials — Local injection-site reactions, systemic effects, immune vs. non-immune reactions, and pharmacovigilance reporting.
- Lyophilized Storage, Stability & Reconstitution Science — Hydrolysis, oxidation, and aggregation pathways, temperature and moisture controls, and laboratory handling procedures.
Editorial & Legal Pages
- Frequently Asked Questions (FAQ) — Answers on evidence levels, regulatory status, storage stability, safety monitoring, and our supplier compliance audit.
- About Delta Peptides — Editorial charter, independence policy, analytical standards, and literature review methodology.
- Reference Resources & Privacy Contact — How the reference resources in the compendium are organized and where to direct privacy inquiries.
- Privacy Policy — Data handling, visitor rights, and privacy disclosures for visitors to deltapeptides.com.
- Terms of Use — Editorial terms, intellectual property, liability limitations, and informational disclaimers.